
Sword Health Stock
Sword Health is a digital musculoskeletal therapy provider that pairs its members with a licensed physical therapist.
Sign up today and learn more about Sword Health Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Sword Health Stock
Sword Health, the world’s fastest growing digital musculoskeletal (MSK) company, believes in the power of people to recover at home, without resorting to imaging, surgeries or opioids. As the first digital solution to pair its members with a licensed physical therapist and the Digital Therapist, Sword delivers a clinically-proven, personalized treatment plan that is easier, more effective and less expensive than the traditional gold standard of care. Now, Sword has expanded into new categories, as part of its mission to free two billion people from pain. Earlier this year it launched Bloom, the first digital pelvic health therapy solution designed to treat the 1 in 4 women who suffer from a pelvic health condition. As of November 2022, Sword is now pioneering a new category of movement health, which combines the focused approach of physical therapy with the whole body appeal of fitness. Every Sword solution leverages technology and human expertise to deliver better engagement and outcomes than traditional healthcare methods. Since entering the market in 2020, Sword Health has worked with insurers, health systems, and employers in the U.S., Canada, Europe, and Australia to make high quality musculoskeletal care, and beyond, accessible to everyone.
Investors
Funding History
April 2015 | $1.3M |
---|---|
July 2015 | $1.3M |
April 2018 | $4.6M |
April 2019 | $8.0M |
February 2020 | $9.0M |
January 2021 | $25.0M |
June 2021 | $85.0M |
November 2021 | $163M |
November 2021 | $26.0M |
Management
Founder & CEO
Virgílio Bento
CMO
Fernando Correia
Founder, CSO
Márcio Colunas
VP of Strategic Business Development
André Santos
VP, Commercial
Kyle Spackman
EVP, Partnerships
Neil Sharma
Chief People Officer
Pavle Stojkovic
Recruiting Manager
Jason Nussbaum
Strategic Advisory Board
Scott Rotermund
Chief Experience Officer
Natasha Prasad
VP, Clinical Operations
Alexandre Droulers
CFO
Valentina Longo
VP of Product
Ivo Gabriel
Regulatory Affairs Officer
Catarina Prata
VP of Algorithms and AI
Luis Ungaro
VP of Engineering
Jorge Meireles
Senior Manager of Sales Enablement
Jose Alejandro Montero
Chief Talent Officer
Thach Nguyen
VP, Finance
Scott Albrecht
Senior Vice President, Customer Success
Kris Davis
Android Developer
António Vieira
Advisor
David Hong
VP of Hardware Products
Daipan Lee
Director of Clinical Operations
André Nogueira
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase